A personalized vaccine may help treat ovarian cancer
Ovarian cancer is often called the “silent killer” because its symptoms are difficult to detect until the cancer has developed into later, deadlier stages. Since it is commonly detected only at an advanced stage, chemotherapy and surgery regularly fail to prevent ovarian cancer from recurring. The five-year survival rate for stage IV invasive epithelial ovarian cancer is a mere 17 percent.